×

Methods and compositions for incorporating nucleotides

  • US 10,174,066 B2
  • Filed: 04/05/2017
  • Issued: 01/08/2019
  • Est. Priority Date: 03/19/2008
  • Status: Active Grant
First Claim
Patent Images

1. A labeled reversible terminator comprising a nucleotide analogue of dATP having a 3′

  • -O group and a label, wherein the label is ROX and is attached to the nucleotide analogue of dATP though a cleavable linker comprising a disulfide bond, and wherein a removable chemical moiety caps the 3′

    -O group, wherein said labeled reversible terminator is in a mixture in solution with an unlabeled reversible terminator comprising a nucleotide analogue of dATP, wherein the concentration of the unlabeled nucleotide analogue of dATP is present in said solution at a higher concentration than the labeled nucleotide analogue of dATP.

View all claims
  • 6 Assignments
Timeline View
Assignment View
    ×
    ×